Welcome New Corporate Member: Universal Cells

Member News  | 

Universal Cells commercializes stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using its proprietary gene editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyte antigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient. This approach avoids the limitations of current allogeneic and autologous cell therapies, as it creates off-the-shelf therapies, with no need for matching of donor cells or for immunosuppression.

Learn more on their website: http://www.universalcells.com/ 


< February 2018 >

Upcoming Events

Contact us

2200 Alaskan Way, Suite 490
Seattle, WA 98121
Get directions

Tel: (206) 443-4703 | Fax: (206) 448-4218 

© 2018 FACC PNW